Not exact matches
Preliminary results
of a study
of patients with prostate cancer show that MR
tractography may be a reliable quantitative imaging biomarker to assess prostate cancer treatment response to androgen deprivation and radiation therapy, according to a team
of researchers at Brigham and Women's Hospital and Massachusetts General Hospital in Boston.
«Diffusion tensor MR
tractography may function as a novel quantitative tool and marker
of treatment response,» said study coauthor Jennifer W. Uyeda, MD, Brigham and Women's Hospital.
Tractography results facilitated intra-operative orientation and electrical stimulation in 28
of 50 (56 %) patients.
In the other patient, navigated TMS indicated abnormal ipsilateral hand motor cortex localization and confirmed the functionality
of aberrant motor cortical representations
of the left foot also indicated by fMRI and DT -
tractography.